话题

#regenxbio

2 篇报道

#biotechnology #clinical-trials #wet-amd #rare-diseases #rgnx #investor-event

股票·2周前

REGENXBIO Inc. (RGNX) 探讨湿性AMD及罕见病临床项目进展与商业前景电话会议纪要

REGENXBIO公司更新了其针对湿性年龄相关性黄斑变性（AMD）及罕见病的临床项目进展，同时探讨了公司的商业化前景。

1697366

股票·2周前

REGENXBIO Inc. To Host Investor Event Transcript

REGENXBIO Inc. hosted an investor event on October 20, 2026, to discuss company updates. A transcript of the event, edited for accuracy, has been made available.

520429512